Boston, MA, United States
Boston, MA, United States

Time filter

Source Type

Patent
Marine Polymer Technology Inc. | Date: 2014-09-05

The present invention relates to compositions comprising semi-crystalline -1-4-N-acetylglucosamine polymers (p-GlcNac) and methods utilizing such polymers modulation of vascular structure and/or function. The compositions and methods disclosed are useful for stimulating, in a p-GlcNac concentration-dependent manner, endothelin-1 release, vasoconstriction, and/or reduction in blood flow out of a breached vessel, as well as for contributing to or effecting cessation of bleeding. The methods of the present invention comprise topical administration of materials comprising semi-crystalline p-GlcNac polymers that are free of proteins, and substantially free of single amino acids as well as other organic and inorganic contaminants, and whose constituent monosaccharide sugars are attached in a -1-4 conformation.


Patent
Marine Polymer Technology Inc. | Date: 2015-10-29

Described herein are compositions comprising shortened fibers of poly-N-acetylglucosamine and/or a derivative thereof (sNAG nanofibers) and anti-bacterial applications of such compositions. The sNAG nanofibers may be formulated into compositions for the prevention and/or treatment of bacterial infections and diseases associated with such infections. Regimens employing such compositions are also described.


Patent
Marine Polymer Technology Inc. | Date: 2014-08-13

The present invention relates generally to the field of hemostasis, including methods, compositions, and devices that can be employed to achieve hemostasis at an increased rate. More specifically the present invention relates to hemostatic compositions that achieve a hemostatic effect at a distance from the site of application of the composition, and a method for administering such a composition to effectively reduce localized vascular complications associated with treating a breach or puncture in a vein or artery and reduce the time to achieve hemostasis.


Patent
Marine Polymer Technology Inc. | Date: 2015-08-17

The present invention relates generally to the field of hemostasis, including methods, compositions, and devices that can be employed to treat wounds. More specifically the present invention relates to hemostatic compositions that reduce the need for, and cost of, nursing care of patients with chronic wounds by reducing the frequency of wound dressing changes.


Patent
Marine Polymer Technology Inc. | Date: 2014-03-13

Described herein are compositions comprising shortened fibers of poly-N-acetylglucosamine and/or a derivative thereof (sNAG nanofibers) and the use of such compositions in the treatment of various diseases, in particular, diseases associated with decreased tensile strength of tissue, decreased elasticity of tissue, increased collagen content or abnormal collagen content in tissue, abnormal alignment of collagen in tissue, and/or increased myofibroblast content in tissue.


Patent
Marine Polymer Technology Inc. | Date: 2014-03-13

Described herein are compositions comprising shortened fibers of poly-N-acetylglucosamine and/or a derivative thereof (sNAG nanofibers) and the use of such compositions in the treatment of various diseases, in particular, diseases associated with decreased tensile strength of tissue, decreased elasticity of tissue, increased collagen content or abnormal collagen content in tissue, abnormal alignment of collagen in tissue, and/or increased myofibroblast content in tissue.


Patent
Marine Polymer Technology Inc. | Date: 2014-07-09

Described herein are compositions comprising shortened fibers of poly-N-acetylglucosamine and/or a derivative thereof (sNAG nanofibers) and anti-bacterial applications of such compositions. The sNAG nanofibers may be formulated into compositions for the prevention and/or treatment of bacterial infections and diseases associated with such infections. Regimens employing such compositions are also described.


Patent
Marine Polymer Technology Inc. | Date: 2016-03-30

The present invention relates generally to methods and compositions that can be employed to treat wounds. More specifically the present invention relates to a composition comprising biocompatible poly--14-N-acetylglucosamine fibers, wherein at least 70% of N-acetylglucosamine monosaccharides of the poly--14-N-acetylglucosamine are acetylated, for use in a method of treatment of a chronic wound in a human subject, wherein the method comprises topically applying the composition to a chronic wound in a human subject in need thereof, and repeating the application of the composition every 5 to 35 days.


Patent
Marine Polymer Technology Inc. | Date: 2013-07-31

The present invention relates generally to the field of hemostasis, including methods, compositions, and devices that can be employed to treat wounds. More specifically the present invention relates to hemostatic compositions that reduce the need for, and cost of, nursing care of patients with chronic wounds by reducing the frequency of wound dressing changes.


Patent
Marine Polymer Technology Inc. | Date: 2013-07-31

The present invention relates generally to the field of hemostasis, including methods, compositions, and devices that can be employed to treat wounds. More specifically the present invention relates to hemostatic compositions that reduce the need for, and cost of, nursing care of patients with chronic wounds by reducing the frequency of wound dressing changes.

Loading Marine Polymer Technology Inc. collaborators
Loading Marine Polymer Technology Inc. collaborators